PHOENIX, Oct. 17, 2019 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today announced the successful clinical commercialization of StemSpine®. StemSpine®, a patented procedure for the treatment of chronic lower back pain (CLBP) utilizing a patient’s own stem cells, has successfully been implemented with …